Display options
Share it on

Auto Immun Highlights. 2018 Feb 12;9(1):3. doi: 10.1007/s13317-018-0102-4.

Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves' disease.

Auto- immunity highlights

Danilo Villalta, Federica D'Aurizio, Mirella Da Re, Debora Ricci, Francesco Latrofa, Renato Tozzoli

Affiliations

  1. Immunology and Allergy Unit, S. Maria degli Angeli Hospital, Pordenone, Italy. [email protected].
  2. Clinical Pathology Laboratory, University Hospital, Udine, Italy.
  3. Immunology and Allergy Unit, S. Maria degli Angeli Hospital, Pordenone, Italy.
  4. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  5. Clinical Pathology Laboratory, S. Maria degli Angeli Hospital, Pordenone, Italy.

PMID: 29435670 PMCID: PMC5809681 DOI: 10.1007/s13317-018-0102-4

Abstract

PURPOSE: Thyrotropin receptor (TSHR) autoantibodies (TRAbs) are a hallmark of Graves' disease (GD). The aim of this study was to evaluate the diagnostic accuracy of a new third generation automatic fluorescence enzyme immunoassay for TRAb measurement in GD, in comparison with two current IMAs.

METHODS: Sera of 439 subjects (57 patients with untreated GD, 34 with treated GD, 15 with GD and Graves' orbitopathy, 52 with multinodular non-toxic goiter, 86 with Hashimoto's thyroiditis, 20 with toxic adenoma or toxic multinodular goiter, 55 with non-thyroid autoimmune diseases and 120 normal controls) were tested for TRAbs with the ELiA

RESULTS: Sensitivity and specificity of the ELiA™ anti-TSH-R assay, TRAK™ RIA and Immulite™ TSI assay were 94.7% and 99.6, 100 and 98.2%, 100 and 98.2%, respectively. Spearman's coefficient and Passing-Bablok regression showed a satisfactory correlation between EliA™ and TRAK™ [rho: 0.925; 95% CI: 0.883-0-953. Intercept: - 0.875 (95% CI: - 2.411 to 0.194); slope: 1.086 (95% CI: 0.941 to 1.248)], and between ELiA

CONCLUSIONS: The diagnostic performance of ELiA

Keywords: ELiA™ anti-TSH-R assay; Graves’ disease (GD); Immunometric assays; Thyrotropin receptor autoantibodies (TRAbs)

References

  1. J Clin Invest. 2002 Jul;110(2):209-17 - PubMed
  2. Thyroid. 2003 Jan;13(1):3-126 - PubMed
  3. J Clin Invest. 2003 Jun;111(12):1897-904 - PubMed
  4. J Clin Pathol. 2004 Apr;57(4):378-82 - PubMed
  5. J Endocrinol Invest. 2004 Mar;27(3):216-20 - PubMed
  6. J Clin Endocrinol Metab. 2004 Sep;89(9):4734-45 - PubMed
  7. J Clin Invest. 2005 Aug;115(8):1972-83 - PubMed
  8. Biochem Biophys Res Commun. 2010 Mar 12;393(3):526-30 - PubMed
  9. Rheumatol Int. 2012 Jan;32(1):73-8 - PubMed
  10. Endocr Pract. 2011 May-Jun;17(3):456-520 - PubMed
  11. J Thyroid Res. 2012;2012:182176 - PubMed
  12. Autoimmun Rev. 2012 Dec;12(2):107-13 - PubMed
  13. Thyroid. 2013 Jan;23(1):14-24 - PubMed
  14. Autoimmun Rev. 2015 Jan;14(1):75-9 - PubMed
  15. Eur Thyroid J. 2015 Mar;4(1):3-5 - PubMed
  16. Horm Metab Res. 2015 Nov;47(12):880-8 - PubMed
  17. Horm Metab Res. 2015 Sep;47(10):727-34 - PubMed
  18. Horm Metab Res. 2015 Sep;47(10):735-52 - PubMed
  19. Clin Chem Lab Med. 2017 Jan 1;55(1):58-64 - PubMed
  20. Thyroid. 2016 Oct;26(10):1343-1421 - PubMed
  21. Horm Metab Res. 2016 Dec;48(12):795-801 - PubMed
  22. Lancet. 1974 Aug 24;2(7878):427-31 - PubMed
  23. Clin Chem. 1993 Apr;39(4):561-77 - PubMed
  24. J Clin Endocrinol Metab. 1998 Jan;83(1):40-6 - PubMed
  25. Endocr Rev. 1998 Dec;19(6):673-716 - PubMed

Publication Types